The Experts below are selected from a list of 318 Experts worldwide ranked by ideXlab platform

Eric C Schneider - One of the best experts on this subject based on the ideXlab platform.

  • influence of Cardiac Surgeon report cards on patient referral by cardiologists in new york state after 20 years of public reporting
    Circulation-cardiovascular Quality and Outcomes, 2013
    Co-Authors: David L Brown, Arnold M Epstein, Eric C Schneider
    Abstract:

    Background—Report cards of risk-adjusted mortality rates of individual Cardiac Surgeons have been publicly available in New York State since 1991. A survey of New York cardiologists in 1996 found that these report cards had little effect on their referral recommendations to Cardiac Surgeons. It is unknown whether the influence of report cards on referral behavior has changed over time. Methods and Results—We surveyed cardiologists in New York State in 2011 to determine their awareness of Cardiac Surgeon report cards, their use of the report card in formulating judgments about the quality of Cardiac Surgeons and selecting Cardiac Surgeons for referral of patients, and discussion of the report with patients in need of Cardiac surgery. The relation between demographic (age, sex) and professional (teaching, board certification, faculty appointment, general cardiology practice, and hospital employee) characteristics and the influence of report cards on referral decisions was assessed using χ2 for categorical v...

David P. Steensma - One of the best experts on this subject based on the ideXlab platform.

  • sir brian gerald barratt boyes pioneer Cardiac Surgeon
    Mayo Clinic Proceedings, 2012
    Co-Authors: Robert A. Kyle, Marc A. Shampo, David P. Steensma
    Abstract:

    N t h F t Dana-Farber Cancer Institute, Boston, MA (D.P.S.). B orn on January 13, 1924, in Wellington, New Zealand, Brian Barratt-Boyes attended Wellington College and then Victoria University, both in Wellington. He graduated in medicine from Otago Medical School (Dunedin, New Zealand) in 1946. He received initial surgical training in New Zealand and then trained with pioneering Cardiac Surgeon John Kirklin at Mayo Clinic in Rochester, Minnesota, from 1953 to 1955. Following a 1-year Nuffield Fellowship in England—a program endowed in 1940 by Viscount Nuffield of Oxford (William Morris, founder of Morris Motors) to support research in health care policy—BarrattBoyes was recruited by Sir Douglas Robb, New Zealand’s pioneer of heart surgery, to Green Lane Hospital in Auckland, New Zealand. At Green Lane, Barratt-Boyes pioneered the development of cardiopulmonary bypass surgery, using this technique for the first time on a patient in New Zealand in 1958. He was also one of the first Surgeons to implant a pacemaker (a prototype built in a university laboratory) in the human heart before these devices became commercially available in 1961. He credited these early successes in part to the remoteness of New Zealand with its accompanying freedom from the distractions of large urban centers, and he compared this to the single-minded devotion that the small city of Rochester had allowed Kirklin. In 1962, independently and almost simultaneously with Donald Ross of London, Barratt-Boyes introduced human cadaveric aortic homografts for aortic valve replacement. He championed the physiologic advantages of such grafts and simplified their surgical implantation technique. He also introduced the use of hypothermia and Cardiac arrest for major surgery in neonates and infants. He was coauthor t

  • Sir Brian Gerald Barratt-Boyes—Pioneer Cardiac Surgeon
    Mayo Clinic proceedings, 2012
    Co-Authors: Robert A. Kyle, Marc A. Shampo, David P. Steensma
    Abstract:

    N t h F t Dana-Farber Cancer Institute, Boston, MA (D.P.S.). B orn on January 13, 1924, in Wellington, New Zealand, Brian Barratt-Boyes attended Wellington College and then Victoria University, both in Wellington. He graduated in medicine from Otago Medical School (Dunedin, New Zealand) in 1946. He received initial surgical training in New Zealand and then trained with pioneering Cardiac Surgeon John Kirklin at Mayo Clinic in Rochester, Minnesota, from 1953 to 1955. Following a 1-year Nuffield Fellowship in England—a program endowed in 1940 by Viscount Nuffield of Oxford (William Morris, founder of Morris Motors) to support research in health care policy—BarrattBoyes was recruited by Sir Douglas Robb, New Zealand’s pioneer of heart surgery, to Green Lane Hospital in Auckland, New Zealand. At Green Lane, Barratt-Boyes pioneered the development of cardiopulmonary bypass surgery, using this technique for the first time on a patient in New Zealand in 1958. He was also one of the first Surgeons to implant a pacemaker (a prototype built in a university laboratory) in the human heart before these devices became commercially available in 1961. He credited these early successes in part to the remoteness of New Zealand with its accompanying freedom from the distractions of large urban centers, and he compared this to the single-minded devotion that the small city of Rochester had allowed Kirklin. In 1962, independently and almost simultaneously with Donald Ross of London, Barratt-Boyes introduced human cadaveric aortic homografts for aortic valve replacement. He championed the physiologic advantages of such grafts and simplified their surgical implantation technique. He also introduced the use of hypothermia and Cardiac arrest for major surgery in neonates and infants. He was coauthor t

Marino Labinaz - One of the best experts on this subject based on the ideXlab platform.

  • transcatheter aortic valve replacement a Cardiac Surgeon and cardiologist team perspective
    Current Opinion in Cardiology, 2010
    Co-Authors: Marc Ruel, Marino Labinaz
    Abstract:

    PURPOSE OF REVIEW Transcatheter aortic-valve implantation is a promising new treatment modality for patients with aortic-valve disease, where it may revolutionize the treatment of elderly and high-risk patients. RECENT FINDINGS The two devices currently available, the Edwards Sapien valve and the Medtronic CoreValve system, are presented. With a focus on the CoreValve, we describe the indications, contraindications, procedural technique, cardiologist and heart Surgeon team dynamics, and special considerations in patients with concomitant cardiopulmonary disease, peripheral arterial disease, low gradient aortic stenosis, and previous bioprosthetic aortic-valve replacement. CONCLUSION We make a case for judicious team-based adoption of these new technologies and emphasize the need for evidence-based and health economics data. We believe that the above will enable determining the therapeutic niche of these modalities amongst the excellent results of conventional aortic-valve replacement surgery.

David L Brown - One of the best experts on this subject based on the ideXlab platform.

  • influence of Cardiac Surgeon report cards on patient referral by cardiologists in new york state after 20 years of public reporting
    Circulation-cardiovascular Quality and Outcomes, 2013
    Co-Authors: David L Brown, Arnold M Epstein, Eric C Schneider
    Abstract:

    Background—Report cards of risk-adjusted mortality rates of individual Cardiac Surgeons have been publicly available in New York State since 1991. A survey of New York cardiologists in 1996 found that these report cards had little effect on their referral recommendations to Cardiac Surgeons. It is unknown whether the influence of report cards on referral behavior has changed over time. Methods and Results—We surveyed cardiologists in New York State in 2011 to determine their awareness of Cardiac Surgeon report cards, their use of the report card in formulating judgments about the quality of Cardiac Surgeons and selecting Cardiac Surgeons for referral of patients, and discussion of the report with patients in need of Cardiac surgery. The relation between demographic (age, sex) and professional (teaching, board certification, faculty appointment, general cardiology practice, and hospital employee) characteristics and the influence of report cards on referral decisions was assessed using χ2 for categorical v...

  • Cardiac Surgeon report cards, referral for Cardiac surgery, and the ethical responsibilities of cardiologists.
    Journal of the American College of Cardiology, 2012
    Co-Authors: David L Brown, Stephen R. Clarke, Justin Oakley
    Abstract:

    Public reporting of clinical outcomes data is but one response to calls for increasing transparency in health care. Cardiac surgical operations are among the most commonly performed complex operative procedures. Risk-adjusted Cardiac surgery mortality rate data for individual Cardiac Surgeons are currently available for >25% of the U.S. population as well as for Great Britain and Ireland. Although cardiologists are the primary source of referral of patients for Cardiac surgery, surveys of cardiologists and analysis of market share data indicate this information is not being used to refer to Cardiac Surgeons with the lowest mortality rates. We review the ethical principles that should obligate cardiologists to discuss and use outcomes data, when available, in selecting Cardiac Surgeons to whom they refer their patients.

Robert A. Kyle - One of the best experts on this subject based on the ideXlab platform.

  • sir brian gerald barratt boyes pioneer Cardiac Surgeon
    Mayo Clinic Proceedings, 2012
    Co-Authors: Robert A. Kyle, Marc A. Shampo, David P. Steensma
    Abstract:

    N t h F t Dana-Farber Cancer Institute, Boston, MA (D.P.S.). B orn on January 13, 1924, in Wellington, New Zealand, Brian Barratt-Boyes attended Wellington College and then Victoria University, both in Wellington. He graduated in medicine from Otago Medical School (Dunedin, New Zealand) in 1946. He received initial surgical training in New Zealand and then trained with pioneering Cardiac Surgeon John Kirklin at Mayo Clinic in Rochester, Minnesota, from 1953 to 1955. Following a 1-year Nuffield Fellowship in England—a program endowed in 1940 by Viscount Nuffield of Oxford (William Morris, founder of Morris Motors) to support research in health care policy—BarrattBoyes was recruited by Sir Douglas Robb, New Zealand’s pioneer of heart surgery, to Green Lane Hospital in Auckland, New Zealand. At Green Lane, Barratt-Boyes pioneered the development of cardiopulmonary bypass surgery, using this technique for the first time on a patient in New Zealand in 1958. He was also one of the first Surgeons to implant a pacemaker (a prototype built in a university laboratory) in the human heart before these devices became commercially available in 1961. He credited these early successes in part to the remoteness of New Zealand with its accompanying freedom from the distractions of large urban centers, and he compared this to the single-minded devotion that the small city of Rochester had allowed Kirklin. In 1962, independently and almost simultaneously with Donald Ross of London, Barratt-Boyes introduced human cadaveric aortic homografts for aortic valve replacement. He championed the physiologic advantages of such grafts and simplified their surgical implantation technique. He also introduced the use of hypothermia and Cardiac arrest for major surgery in neonates and infants. He was coauthor t

  • Sir Brian Gerald Barratt-Boyes—Pioneer Cardiac Surgeon
    Mayo Clinic proceedings, 2012
    Co-Authors: Robert A. Kyle, Marc A. Shampo, David P. Steensma
    Abstract:

    N t h F t Dana-Farber Cancer Institute, Boston, MA (D.P.S.). B orn on January 13, 1924, in Wellington, New Zealand, Brian Barratt-Boyes attended Wellington College and then Victoria University, both in Wellington. He graduated in medicine from Otago Medical School (Dunedin, New Zealand) in 1946. He received initial surgical training in New Zealand and then trained with pioneering Cardiac Surgeon John Kirklin at Mayo Clinic in Rochester, Minnesota, from 1953 to 1955. Following a 1-year Nuffield Fellowship in England—a program endowed in 1940 by Viscount Nuffield of Oxford (William Morris, founder of Morris Motors) to support research in health care policy—BarrattBoyes was recruited by Sir Douglas Robb, New Zealand’s pioneer of heart surgery, to Green Lane Hospital in Auckland, New Zealand. At Green Lane, Barratt-Boyes pioneered the development of cardiopulmonary bypass surgery, using this technique for the first time on a patient in New Zealand in 1958. He was also one of the first Surgeons to implant a pacemaker (a prototype built in a university laboratory) in the human heart before these devices became commercially available in 1961. He credited these early successes in part to the remoteness of New Zealand with its accompanying freedom from the distractions of large urban centers, and he compared this to the single-minded devotion that the small city of Rochester had allowed Kirklin. In 1962, independently and almost simultaneously with Donald Ross of London, Barratt-Boyes introduced human cadaveric aortic homografts for aortic valve replacement. He championed the physiologic advantages of such grafts and simplified their surgical implantation technique. He also introduced the use of hypothermia and Cardiac arrest for major surgery in neonates and infants. He was coauthor t